157 related articles for article (PubMed ID: 34939666)
21. National incidence of eyelid cancer in Ireland (2005-2015).
Quigley C; Deady S; Hughes E; McElnea E; Zgaga L; Chetty S
Eye (Lond); 2019 Oct; 33(10):1534-1539. PubMed ID: 30976073
[TBL] [Abstract][Full Text] [Related]
22. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
23. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995.
Hannuksela-Svahn A; Pukkala E; Karvonen J
Arch Dermatol; 1999 Jul; 135(7):781-6. PubMed ID: 10411152
[TBL] [Abstract][Full Text] [Related]
24. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
25. Basal cell carcinoma of the eyelid in Finland during 1953-97.
Paavilainen V; Tuominen J; Pukkala E; Saari KM
Acta Ophthalmol Scand; 2005 Apr; 83(2):215-20. PubMed ID: 15799736
[TBL] [Abstract][Full Text] [Related]
26. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
Krynitz B; Olsson H; Lundh Rozell B; Lindelöf B; Edgren G; Smedby KE
Br J Dermatol; 2016 Jan; 174(1):95-103. PubMed ID: 26333521
[TBL] [Abstract][Full Text] [Related]
27. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.
Rudolph C; Schnoor M; Eisemann N; Katalinic A
J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814
[TBL] [Abstract][Full Text] [Related]
28. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
[TBL] [Abstract][Full Text] [Related]
29. Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10).
Musah A; Gibson JE; Leonardi-Bee J; Cave MR; Ander EL; Bath-Hextall F
Br J Dermatol; 2013 Nov; 169(5):1093-9. PubMed ID: 23701520
[TBL] [Abstract][Full Text] [Related]
30. The incidence of basal cell carcinoma in Croatia: an epidemiological study.
Celić D; Lipozencić J; Jurakić Toncić R; Ledić-Drvar D; Marasović D; Puizina-Ivić N; Cabrijan L; Bradamante M
Acta Dermatovenerol Croat; 2009; 17(2):108-12. PubMed ID: 19595266
[TBL] [Abstract][Full Text] [Related]
31. Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
Hammas K; Nardin C; Boyer S; Michel C; Aubin F; Woronoff AS
Br J Dermatol; 2024 May; ():. PubMed ID: 38748494
[TBL] [Abstract][Full Text] [Related]
32. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
34. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of worldwide incidence of nonmelanoma skin cancer.
Lomas A; Leonardi-Bee J; Bath-Hextall F
Br J Dermatol; 2012 May; 166(5):1069-80. PubMed ID: 22251204
[TBL] [Abstract][Full Text] [Related]
36. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients.
Chang JM; Gao XM
Chin Med J (Engl); 2013 Jan; 126(2):211-4. PubMed ID: 23324265
[TBL] [Abstract][Full Text] [Related]
37. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
38. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
[TBL] [Abstract][Full Text] [Related]
39. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.
Chuang TY; Reizner GT; Elpern DJ; Stone JL; Farmer ER
J Am Acad Dermatol; 1995 Sep; 33(3):422-6. PubMed ID: 7657865
[TBL] [Abstract][Full Text] [Related]
40. Basal cell carcinoma: Epidemiological impact of clinical versus histopathological diagnosis.
Backman E; Oxelblom M; Gillstedt M; Dahlén Gyllencreutz J; Paoli J
J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):521-527. PubMed ID: 36433707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
